| ASSET | YEAR | % RETURN |
|---|---|---|
Sarepta Therapeutics (SRPT) | 2010 | 43.24% |
Sarepta Therapeutics (SRPT) | 2011 | -65.35% |
Sarepta Therapeutics (SRPT) | 2012 | 469.54% |
Sarepta Therapeutics (SRPT) | 2013 | -25.06% |
Sarepta Therapeutics (SRPT) | 2014 | -28.58% |
Sarepta Therapeutics (SRPT) | 2015 | 164.61% |
Sarepta Therapeutics (SRPT) | 2016 | -27.53% |
Sarepta Therapeutics (SRPT) | 2017 | 96.26% |
Sarepta Therapeutics (SRPT) | 2018 | 95.33% |
Sarepta Therapeutics (SRPT) | 2019 | 19.59% |
Sarepta Therapeutics (SRPT) | 2020 | 31.52% |
Sarepta Therapeutics (SRPT) | 2021 | -47.34% |
Sarepta Therapeutics (SRPT) | 2022 | 43.82% |
Sarepta Therapeutics (SRPT) | 2023 | -25.07% |
Sarepta Therapeutics (SRPT) | 2024 | 27.32% |
Sarepta Therapeutics (SRPT) | 2025 | -81.91% |
